Surgeons have described a new treatment for early-stage prostate cancer as "highly ". The treatment, tested across Europe, there used lasers and a mixture of drugs containing bacteria from the sea bottom to eliminate tumors, but without causing serious side effects.
Tests on 413 people, published in "The Lancet Oncology", shows that nearly half of them had no trace of testicular tumor. Long-term impotence and lack of self are often consequences of prostate cancer treatment with surgery or radiotherapy. Almost 9 in 10 patients face problems genitals, while 2 in 10 have problems with bladder.
This is also the reason why men to detect cancer in early stages of adopting "wait and see", while receiving cancer treatments only when further advances in aggressive stages.
"This development changes everything," said Professor Mark Emberton, who tested the technique in question at University College London.
The new treatment uses a drug produced by bacteria that live in almost complete darkness in the basement of the seas, returning to toxic substances when exposed to light. Optical lasers are then through the perineum, or the space between the anus and testicles, to cancerous prostate glands. When red laser light, it activates the drugs in question to kill cancerous cells and what remains is healthy prostate.
Testing conducted at 47 European hospitals showed that 49 percent of patients were healed. Meanwhile, after this test, only 6 percent of patients had to perform surgery to remove the prostate, compared to 30 percent of patients who do something like that before used this new therapy. And more importantly, the impact on sexual activity and urination lasted no more than 3 months. Of those who have undergone this therapy, there were no male side effects after two years.
0 comments:
Post a Comment